Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
podcast
Podcast
How Boehringer Ingelheim is buttressing its US business
In this episode of “The Top Line,” we dive into Boehringer Ingelheim’s latest regulatory wins, two key launches, and its U.S. commercialization push.
Ayla Ellison
,
Fraiser Kansteiner
Oct 10, 2025 9:00am
A whirlwind week for pharma
Oct 3, 2025 9:00am
Sponsored
Salesforce’s Mark Sullivan: AI and agentic systems will redefine life sciences
Oct 14, 2025 12:16pm
Rebuilding pharma’s credibility in the age of misinformation
Sep 19, 2025 9:47am
Inside the commercial growing pains of hemophilia gene therapies
Sep 12, 2025 10:00am
A rare kind of leadership, 30 years in the making
Sep 5, 2025 8:56am